Résumé
The efficacy of antineoplastic chemotherapies with anthracyclines or oxaliplatin relies on the induction of immunogenic cell death, thus provoking an anticancer immune response. Recently, we observed that overexpression of CD39, an ATPdegrading enzyme expressed on the cell surface, abolishes the immunogenicity of cell death, thus rendering cancers resistant against chemotherapy.
langue originale | Anglais |
---|---|
Pages (de - à) | 393-395 |
Nombre de pages | 3 |
journal | OncoImmunology |
Volume | 1 |
Numéro de publication | 3 |
Les DOIs | |
état | Publié - 1 nov. 2012 |